“…Very recently, it was demonstrated that so-called 'AdipoRon', an orally active, synthetic small-molecule adiponectin receptor agonist, significantly improved insulin sensitivity and glucose tolerance in mice [45]. In high fat-fed db/db mice, treatment with AdipoRon extended longevity [45] supporting previous suggestions that high adiponectin serum concentrations are associated with prolonged life span in obesity [46]. Of note, adiponectin levels have been shown to inversely correlate with obesity, visceral fat distribution, T2DM, and other obesity-related diseases [32,39,43].…”